SEC Form 4
Covista Inc. (CVSA) insider trading
In the 12 months to Oct 26, 2026, 5 CVSA insiders reported open-market sales of $10.3M across 13 filings; one director bought $3.8M.
Latest filing · Last 12 months · Source: SEC EDGAR · How we count
- Open-market sales
- $10.3M
- 13 filings · 5 insiders
- Open-market purchases
- $3.8M
- 2 filings · Michael W. Malafronte, Director
- Pre-arranged sales (10b5-1)
- 13 of 13
- All $10.3M sold was pre-arranged
Who traded CVSA, and when
- Purchase
- Sale
- Sale, pre-arranged (10b5-1)
CVSA daily close from Feb 24, 2026 to Oct 26, 2026, between $96.07 and $140.98, last $131.32. 13 sale and 2 purchase filings by 6 insiders, marked at their filing dates. Stephen W. Beard, Chairman & CEO: sold $5.0M across 5 filings, first filed May 12, 2026, last Oct 9, 2026. Michael W. Malafronte, Director: bought $3.8M across 2 filings, first filed Mar 5, 2026, last Mar 12, 2026. Douglas G. Beck, SVP, GC, Corp. Sec & ISS: sold $2.5M across 3 filings, first filed May 12, 2026, last Aug 11, 2026. Robert J. Phelan, Chief Financial Officer: sold $2.3M across 3 filings, first filed May 12, 2026, last Aug 11, 2026. Karen Sue Cox, President, Chamberlain Univ.: sold $249.0K across 1 filing, first filed May 12, 2026, last May 12, 2026. Manjunath Gangadharan, VP, Chief Accounting Officer: sold $247.2K across 1 filing, first filed Aug 28, 2026, last Aug 28, 2026.
Largest mark · tap a row for others
Michael W. Malafronte · Director
Purchase $3,635,414
36,036 shares at $100.88 avg
Filed Mar 12, 2026 · traded Mar 10
Close on filing date $103.84
Stephen W. Beard · Chairman & CEO
Chairman & CEO
$5.0M soldMichael W. Malafronte · Director
Director
$3.8M boughtDouglas G. Beck · SVP, GC, Corp. Sec & ISS
SVP, GC, Corp. Sec & ISS
$2.5M soldRobert J. Phelan · Chief Financial Officer
Chief Financial Officer
$2.3M soldKaren Sue Cox · President, Chamberlain Univ.
President, Chamberlain Univ.
$249.0K soldManjunath Gangadharan · VP, Chief Accounting Officer
VP, Chief Accounting Officer
$247.2K soldOpen-market trades
15 filings in the last 12 months| Insider | Role | Sold | Bought | Filings | Pre-arranged (10b5-1) | Last filed |
|---|---|---|---|---|---|---|
| Stephen W. Beard | Chairman & CEO | $5.0M | — | 5 | 100% of sales | |
| Michael W. Malafronte | Director | — | $3.8M | 2 | — | |
| Douglas G. Beck | SVP, GC, Corp. Sec & ISS | $2.5M | — | 3 | 100% of sales | |
| Robert J. Phelan | Chief Financial Officer | $2.3M | — | 3 | 100% of sales | |
| Karen Sue Cox | President, Chamberlain Univ. | $249.0K | — | 1 | 100% of sales | |
| Manjunath Gangadharan | VP, Chief Accounting Officer | $247.2K | — | 1 | 100% of sales |
| Filed | Insider | Type | Shares | Avg price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|
traded | Stephen W. Beard Chairman & CEO | SalePre-arranged (10b5-1) | 8,306 | $130.59 | $1.1M | 469,158 | |
traded | Manjunath Gangadharan VP, Chief Accounting Officer | SalePre-arranged (10b5-1) | 1,802 | $137.18 | $247.2K | 5,083 | |
traded | Stephen W. Beard Chairman & CEO | SalePre-arranged (10b5-1) | 3,545 | $130.35 | $462.1K | 415,197 | |
traded | Douglas G. Beck SVP, GC, Corp. Sec & ISS | SalePre-arranged (10b5-1) | 4,526 | $135.81 | $614.7K | 28,544 | |
traded | Robert J. Phelan Chief Financial Officer | SalePre-arranged (10b5-1) | 2,186 | $135.15 | $295.4K | 48,306 | |
traded | Stephen W. Beard Chairman & CEO | SalePre-arranged (10b5-1) | 5,291 | $132.75 | $702.4K | 418,742 | |
traded | Douglas G. Beck SVP, GC, Corp. Sec & ISS | SalePre-arranged (10b5-1) | 5,089 | $135.37 | $688.9K | 33,070 | |
traded | Robert J. Phelan Chief Financial Officer | SalePre-arranged (10b5-1) | 5,314 | $135.40 | $719.5K | 50,492 | |
traded | Stephen W. Beard Chairman & CEO | SalePre-arranged (10b5-1) | 5,291 | $130.45 | $690.2K | 424,033 | |
traded | Stephen W. Beard Chairman & CEO | SalePre-arranged (10b5-1) | 15,874 | $131.25 | $2.1M | 429,324 | |
traded | Karen Sue Cox President, Chamberlain Univ. | SalePre-arranged (10b5-1) | 2,000 | $124.50 | $249.0K | 31,596 | |
traded | Douglas G. Beck SVP, GC, Corp. Sec & ISS | SalePre-arranged (10b5-1) | 9,615 | $127.03 | $1.2M | 38,159 | |
traded | Robert J. Phelan Chief Financial Officer | SalePre-arranged (10b5-1) | 10,000 | $126.21 | $1.3M | 55,806 | |
traded | Michael W. Malafronte Director | Purchase | 36,036 | $100.88 | $3.6M | Multiple accounts | |
traded | Michael W. Malafronte Director | Purchase | 1,200 | $97.97 | $117.6K | 1,200 |
GET /stocks/filings/vX/form-4?tickers=CVSA&filing_date.gte=2025-10-26&sort=filing_date.desc&limit=500{
"status": "OK",
"results": [
{
"tickers": [
"CVSA"
],
"issuer_cik": "0000730464",
"owner_cik": "0001508595",
"accession_number": "0000730464-26-000057",
"form_type": "4",
"filing_date": "2026-10-09",
"period_of_report": "2026-10-08",
"issuer_name": "Covista Inc.",
"issuer_trading_symbol": "CVSA",
"owner_name": "Beard, Stephen W.",
"is_officer": true,
"officer_title": "Chairman & CEO",
"security_type": "non_derivative",
"record_type": "transaction",
"security_title": "Common Stock",
"transaction_timeliness": "O",
"aff_10b5_one": true,
"transaction_date": "2026-10-08",
"transaction_code": "S",
"equity_swap_involved": false,
"transaction_shares": 3639,
"transaction_price_per_share": 130.369,
"transaction_acquired_disposed": "D",
"shares_owned_following_transaction": 473825,
"transaction_value": 474412.791,
"direct_or_indirect": "D",
"footnotes": [
{
"id": "F1",
"description": "This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 10, 2025 in accordance with Covista's Insider Sales and Ownership Policy Addendum."
},
{
"id": "F2",
"description": "Shares sold represent a portion of holdings in excess of Covista's Stock Ownership and Holding Requirements and were executed in pre-scheduled increments under the trading plan."
},
{
"id": "F3",
"description": "No discretionary trades by the reporting person are permitted under Covista policy; all sales must occur pursuant to a pre-established Rule 10b5-1 trading plan absent a hardship exception."
},
{
"id": "F4",
"description": "This transaction was executed in multiple trades at prices ranging from $130.005 to $131.042. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."
}
]
},
{
"tickers": [
"CVSA"
],
"issuer_cik": "0000730464",
"owner_cik": "0001508595",
"accession_number": "0000730464-26-000057",
"form_type": "4",
"filing_date": "2026-10-09",
"period_of_report": "2026-10-08",
"issuer_name": "Covista Inc.",
"issuer_trading_symbol": "CVSA",
"owner_name": "Beard, Stephen W.",
"is_officer": true,
"officer_title": "Chairman & CEO",
"security_type": "non_derivative",
"record_type": "transaction",
"security_title": "Common Stock",
"transaction_timeliness": "O",
"aff_10b5_one": true,
"transaction_date": "2026-10-09",
"transaction_code": "S",
"equity_swap_involved": false,
"transaction_shares": 4667,
"transaction_price_per_share": 130.769,
"transaction_acquired_disposed": "D",
"shares_owned_following_transaction": 469158,
"transaction_value": 610298.9230000001,
"direct_or_indirect": "D",
"footnotes": [
{
"id": "F1",
"description": "This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 10, 2025 in accordance with Covista's Insider Sales and Ownership Policy Addendum."
},
{
"id": "F2",
"description": "Shares sold represent a portion of holdings in excess of Covista's Stock Ownership and Holding Requirements and were executed in pre-scheduled increments under the trading plan."
},
{
"id": "F3",
"description": "No discretionary trades by the reporting person are permitted under Covista policy; all sales must occur pursuant to a pre-established Rule 10b5-1 trading plan absent a hardship exception."
},
{
"id": "F5",
"description": "This transaction was executed in multiple trades at prices ranging from $130.01 to $131.37. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."
}
]
}
]
}
// trimmed to 2 resultsThe response includes every Form 4 record; this page keeps open-market purchases and sales on common stock and removes duplicate joint-filer rows.
Other insider activity (not market trades) · 32 records
- Tax withholding18 records
- Grants and awards13 records
- Gifts1 record
Reported on Form 4 but not purchases or sales in the market, so not counted in the totals above.
How to read this page
- Open-market purchase or sale
- A buy or sell of the company's stock at market price. Grants, option exercises, shares withheld for tax, gifts and employee stock plan purchases are listed separately and not counted.
- Pre-arranged (10b5-1)
- The insider marked the filing as made under a trading plan set up in advance (SEC Rule 10b5-1). The mark covers the whole filing, and an unmarked filing may still be under a plan.
- Filing date
- Insiders have two business days to report a trade. Totals and the chart use the filing date, when the trade became public.
Frequently asked questions
Has Covista Inc.'s CEO sold stock?
Yes. Stephen W. Beard (CEO) sold 38,307 shares ($5.0M) between May 2026 and Oct 2026, all under a pre-arranged 10b5-1 plan.
How current is CVSA’s insider data?
These are CVSA Form 4 filings from the last year, refreshed daily. The Massive Form 4 API has the full, continuously updated record.
What counts as an open-market buy or sell?
Only purchases and sales at the market price. Option exercises, grants, gifts, and shares withheld for taxes are reported on Form 4 but are left out of the buy and sell totals.
Build with AI
Track CVSA insider trades with your agent
This page joins two Massive endpoints: Form 4 filings and daily prices. Ask an agent to watch for new filings:
Using the Massive API (massive.com/docs/llms.txt), check Form 4 filings for CVSA every day with transaction_code=P and tell me when an insider files an open-market purchase, with their role, shares, price and the filing link.
Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.